OmniSeq is a company that provides molecular diagnostic laboratory services. It utilizes next generation sequencing (NGS) technologies through molecular profiling and offers a range of pharmaceutical services to assist in drug development. The company provides tools enabling medical professionals to identify appropriate treatments specific to a patient’s cancer and immune profile.

Employee Rating

3.3More
TypeSubsidiary
HQBuffalo, NY, US
Founded2015
Websiteomniseq.com
Cybersecurity ratingBMore
OmniSeq was founded in 2015 and is headquartered in Buffalo, NY, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at OmniSeq

Carl Morrison

Carl Morrison

Founder
Sean Glenn

Sean Glenn

SVP, Laboratory Operations and Research Development, Assistant Laboratory Director
Shengle Zhang

Shengle Zhang

Laboratory Director
Show more

OmniSeq Office Locations

OmniSeq has an office in Buffalo
Buffalo, NY, US (HQ)
Hauptman Woodward Medical Research Institute, 700 Ellicott St
Show all (1)

OmniSeq Financials and Metrics

Summary Metrics

Founding Date

2015

Total Funding

$11.6 m

Investors

In total, OmniSeq had raised $11.6 m

OmniSeq Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

OmniSeq Online and Social Media Presence

Embed Graph

OmniSeq Company Culture

  • Overall Culture

    C

    70/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A+

    95/100

Learn more on Comparably

OmniSeq News and Updates

OmniSeq Receives New York State Approval for OmniSeq INSIGHT Genomic and Immune Profiling Test

BUFFALO, N.Y., April 28, 2021 /PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health's Clinical Laboratory Evaluation Program has approved the OmniSeq INSIGHTSM test. The test detects genomic variants,...

OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical Study

BUFFALO, N.Y., Jan. 28, 2021 /PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing in oncology, today announced its collaboration with the University of Pittsburgh Medical Center (UPMC) to employ its RNA sequencing (RNA-seq) gene expression profile assay for selecting...

OmniSeq Receives ISO Certification for Quality Management Systems

BUFFALO, N.Y., Dec. 1, 2020 /PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the company has received the International Organization for Standards (ISO) 13485:2016 certification for its Quality Management Systems (QMS). ISO 13485:2016...

OmniSeq Blogs

Assistant Laboratory Director

Labcorp Oncology / OmniSeq, Inc. is seeking a molecular pathologist, with significant Next Generation Sequencing (NGS) experience to perform molecular pathology responsibilities as an assistant laboratory director in a CAP/CLIA/ISO-certified molecular diagnostic laboratory. The individual will be re…

OmniSeq is excited to announce it is now part of Labcorp!

The post OmniSeq is excited to announce it is now part of Labcorp! appeared first on OmniSeq.

Inflammation Signature May Predict Checkpoint Inhibitor Response in Gastroesophageal Cancer, Study Finds

The post Inflammation Signature May Predict Checkpoint Inhibitor Response in Gastroesophageal Cancer, Study Finds appeared first on OmniSeq.

Medical Office Administrative Assistant

Job Description Omniseq is currently seeking an experienced medical office administrative assistant to join our team focused on providing excellent customer service. The ideal candidate would have small medical office experience, with a knowledge of medical terminology. This position also provides o…

Labcorp and OnmiSeq Launch Insight, Next-Generation Sequencing Platform to Advance Precision Oncology

The post Labcorp and OnmiSeq Launch Insight, Next-Generation Sequencing Platform to Advance Precision Oncology appeared first on OmniSeq.

OmniSeq Receives New York State Approval for Cancer Genomic, Immune Profiling Test

The post OmniSeq Receives New York State Approval for Cancer Genomic, Immune Profiling Test appeared first on OmniSeq.
Show more

OmniSeq Frequently Asked Questions

  • When was OmniSeq founded?

    OmniSeq was founded in 2015.

  • Who are OmniSeq key executives?

    OmniSeq's key executives are Carl Morrison, Sean Glenn and Shengle Zhang.

  • How many employees does OmniSeq have?

    OmniSeq has 41 employees.

  • Who are OmniSeq competitors?

    Competitors of OmniSeq include Hubro Therapeutics, Stamford Pharmaceuticals and Immunetune.

  • Where is OmniSeq headquarters?

    OmniSeq headquarters is located at Hauptman Woodward Medical Research Institute, 700 Ellicott St, Buffalo.

  • Where are OmniSeq offices?

    OmniSeq has an office in Buffalo.

  • How many offices does OmniSeq have?

    OmniSeq has 1 office.